Clinical Trial Update: Osteosarcoma Maintenance Therapy With OST31-164 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating OST31-164 as maintenance therapy for osteosarcoma (bone cancer); sponsored by Emerald Clinical Inc. The study is currently lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• OST31-164

Snippet

Sponsor: Emerald Clinical Inc. | Conditions: Bone Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING